Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LIANNE S GENSLER

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1780781369
CMS profile
171478
Location
SAN FRANCISCO, CA

General Payments · PY2018–2024

$399,872.66

  • Reported across 227 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$17,496.46

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $17,231.00 4
Food and Beverage $265.46 10

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
UCB, Inc. $10,089.82 5
Novartis Pharma AG $2,596.00 1
Janssen Scientific Affairs, LLC $2,565.00 1
UCB SA $2,130.00 1
Janssen Biotech, Inc. $115.64 6

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $122,050.12 77
PY2019 $102,516.60 67
PY2020 $30,509.88 11
PY2021 $35,421.29 21
PY2022 $42,158.34 17
PY2023 $49,719.97 20
PY2024 $17,496.46 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Janssen Biotech, Inc. $36.19 03/02/2024 Food and Beverage Undisputed 01/23/2026 1078331924 CMS
Janssen Biotech, Inc. $11.61 03/13/2024 Food and Beverage Undisputed 01/23/2026 1078332745 CMS
Janssen Biotech, Inc. $35.02 08/15/2024 Food and Beverage Undisputed 01/23/2026 1078331830 CMS
Janssen Biotech, Inc. $15.31 09/16/2024 Food and Beverage Undisputed 01/23/2026 1078330121 CMS
Janssen Biotech, Inc. $8.29 11/21/2024 Food and Beverage Undisputed 01/23/2026 1078331168 CMS
Janssen Biotech, Inc. $9.22 12/31/2024 Food and Beverage Undisputed 01/23/2026 1078332242 CMS
Janssen Scientific Affairs, LLC $2,565.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1078845759 CMS
Novartis Pharma AG $2,596.00 09/10/2024 Consulting Fee Undisputed 01/23/2026 1152815181 CMS
UCB SA $2,130.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1113950695 CMS
UCB, Inc. $24.95 03/24/2024 Food and Beverage Undisputed 01/23/2026 1143019215 CMS
UCB, Inc. $24.95 03/24/2024 Food and Beverage Undisputed 01/23/2026 1143019217 CMS
UCB, Inc. $49.96 03/24/2024 Food and Beverage Undisputed 01/23/2026 1143019219 CMS
UCB, Inc. $49.96 03/24/2024 Food and Beverage Undisputed 01/23/2026 1143019221 CMS
UCB, Inc. $9,940.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1143019223 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.